Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Hallador Energy
HNRG
$730M
| $4.12M | ﹤0.01% |
761,755
-56,200
| -7% | -$272K |
|
|
CLVS
1702
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.12M | ﹤0.01% |
2,288,300
+828,400
| +57% | +$1.22M |
|
1703
iShares Biotechnology ETF
IBB
$9.77B
| $4.12M | ﹤0.01% |
35,000
+33,400
| +2,088% | +$3.96M |
|
1704
ATI
ATI
$30.9B
| $4.1M | ﹤0.01% |
180,392
+108,600
| +151% | +$2.86M |
|
1705
Vanguard Long-Term Treasury ETF
VGLT
$10.4B
| $4.09M | ﹤0.01% |
+58,300
| New | +$4.19M |
|
|
STKL
1706
DELISTED
SunOpta
STKL
| $4.09M | ﹤0.01% |
525,596
+202,700
| +63% | +$1.34M |
|
1707
Kirby Corp
KEX
$7.26B
| $4.09M | ﹤0.01% |
67,200
+49,100
| +271% | +$3.2M |
|
|
DNB
1708
DELISTED
Dun & Bradstreet
DNB
| $4.08M | ﹤0.01% |
271,800
+98,700
| +57% | +$1.59M |
|
1709
Xencor
XNCR
$1.71B
| $4.07M | ﹤0.01% |
148,800
-86,100
| -37% | -$2.12M |
|
|
CSW
1710
CSW Industrials
CSW
$5.59B
| $4.07M | ﹤0.01% |
39,500
+23,900
| +153% | +$2.55M |
|
1711
BorgWarner
BWA
$13.8B
| $4.06M | ﹤0.01% |
+138,251
| New | +$4.55M |
|
1712
MetLife
MET
$61.9B
| $4.06M | ﹤0.01% |
+64,600
| New | +$4.28M |
|
|
OMCC
1713
DELISTED
Old Market Capital Corp
OMCC
| $4.05M | ﹤0.01% |
434,949
-14,289
| -3% | -$140K |
|
1714
Preformed Line Products
PLPC
$2.19B
| $4.05M | ﹤0.01% |
65,900
-574
| -0.9% | -$35.5K |
|
1715
Erie Indemnity
ERIE
$13.4B
| $4.04M | ﹤0.01% |
21,041
+5,470
| +35% | +$951K |
|
1716
Southwest Gas
SWX
$6.67B
| $4.04M | ﹤0.01% |
+46,400
| New | +$4.09M |
|
|
SHOE
1717
Shoe Station Group
SHOE
$415M
| $4.04M | ﹤0.01% |
186,968
+137,393
| +277% | +$3.91M |
|
1718
CRH
CRH
$65B
| $4.04M | ﹤0.01% |
116,000
+51,300
| +79% | +$2M |
|
1719
IQVIA
IQV
$39.8B
| $4.04M | ﹤0.01% |
18,600
-13,300
| -42% | -$2.89M |
|
|
TPIC
1720
DELISTED
TPI Composites
TPIC
| $4.01M | ﹤0.01% |
321,191
-240,209
| -43% | -$3.15M |
|
|
OLO
1721
DELISTED
Olo Inc
OLO
| $4M | ﹤0.01% |
405,200
-632,800
| -61% | -$6.89M |
|
1722
Caesarstone
CSTE
$105M
| $4M | ﹤0.01% |
437,518
+15,300
| +4% | +$146K |
|
|
TBI
1723
Trueblue
TBI
$309M
| $3.99M | ﹤0.01% |
223,000
+52,300
| +31% | +$1.23M |
|
|
ASAI
1724
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $3.99M | ﹤0.01% |
293,700
+91,300
| +45% | +$1.44M |
|
1725
EverQuote
EVER
$864M
| $3.98M | ﹤0.01% |
449,708
-39,800
| -8% | -$454K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.